View Exam | PowerPak

1. Which of the following describes an immune-related change in the elderly population?

A. Increased uptake of antigens B. Increased expression of macrophages C. Increased memory T cells D. Decreased memory B cells E. Unsure

2. Which of the following contributes to inflammaging?

A. Increased stimulation of the adaptive immune system B. Reduced integrity of the intestinal epithelial barrier C. Decreased adipose tissue accumulation in the body D. A shift to a chronic anti-inflammatory state with aging E. Unsure

3. How efficacious is the recombinant herpes zoster vaccine for postherpetic neuralgia prevention in patients 70 years or older?

A. 66.6% B. 77.7% C. 88.8% D. 99.9% E. Unsure

4. Leslie, a 60-year-old woman, tells you that her husband Ben had a shingles rash on his abdomen that resolved 2 weeks ago, but he has been complaining that wearing a shirt hurts his skin. He did not receive a herpes zoster vaccine. What is Ben experiencing?

A. Encephalitis B. Allodynia C. Rhabdomyolysis D. Shingles rash E. Unsure

5. Which of these complications is the most likely consequence of skipping influenza vaccination?

A. Asthma exacerbation B. Hearing loss C. Blindness D. Pericarditis E. Unsure

6. Which best describes a potential barrier to herpes zoster vaccination?

A. Patients prefer the 1 vaccine shot that is no longer available B. Patients consider shingles a more serious, lasting disease C. Patients know shingles treatment is cheaper than the vaccine D. Patients require 2 doses of RZV for adequate protection E. Unsure

7. When considering CDC's “SHARE” model, which of the following is an appropriate way to address patients' barriers to vaccine administration?

A. SHARE what risk factors make a vaccine right for the patient B. HIGHLIGHT possible complications of the disease C. REMIND patients about the second dose, when appropriate D. EXPLAIN the science behind how the vaccine works E. Unsure

8. Which of the following vaccines is NOT paid for by Medicare Part B?

A. High-dose IIV3 B. PCV13 C. PPSV23 D. RZV E. Unsure

9. Anne is a 70-year-old patient who comes to your pharmacy for an influenza vaccine. She received her first dose of RZV at your location 3 months ago and PCV13 16 months ago. Which is the most appropriate recommendation for Anne?

A. Offer to set her a reminder to come back for PPSV23 in 2 weeks B. Recommend that she receive the 2nd dose of RZV today C. Offer to set her a reminder to come back for the 2nd RZV dose in 3 months D. Recommend that she receive PPSV23 and the 2nd dose of RZV today E. Unsure

10. Ron is a 65-year-old patient who comes to your pharmacy for a PCV13 vaccine at the recommendation of his physician. Given his vaccine history, what other vaccine do you recommend he get today?

Today’s date: 10/07/2020

Herpes zoster ZVL 06/07/2016
RZV 02/13/2020

Tetanus 05/15/2015

Pneumococcal No history

Influenza 08/07/2020

A. Second dose of RZV B. Re-start the 2-dose series of RZV C. PPSV23 instead of PCV13 D. None, PCV13 should not be given with other vaccines E. Unsure

*Herpes zoster*	ZVL 06/07/2016 RZV 02/13/2020
*Tetanus*	05/15/2015
*Pneumococcal*	No history
*Influenza*	08/07/2020

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following describes an immune-related change in the elderly population?

2. Which of the following contributes to inflammaging?

3. How efficacious is the recombinant herpes zoster vaccine for postherpetic neuralgia prevention in patients 70 years or older?

4. Leslie, a 60-year-old woman, tells you that her husband Ben had a shingles rash on his abdomen that resolved 2 weeks ago, but he has been complaining that wearing a shirt hurts his skin. He did not receive a herpes zoster vaccine. What is Ben experiencing?

5. Which of these complications is the most likely consequence of skipping influenza vaccination?

6. Which best describes a potential barrier to herpes zoster vaccination?

7. When considering CDC's “SHARE” model, which of the following is an appropriate way to address patients' barriers to vaccine administration?

8. Which of the following vaccines is NOT paid for by Medicare Part B?

9. Anne is a 70-year-old patient who comes to your pharmacy for an influenza vaccine. She received her first dose of RZV at your location 3 months ago and PCV13 16 months ago. Which is the most appropriate recommendation for Anne?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following describes an immune-related change in the elderly population?

2. Which of the following contributes to inflammaging?

3. How efficacious is the recombinant herpes zoster vaccine for postherpetic neuralgia prevention in patients 70 years or older?

4. Leslie, a 60-year-old woman, tells you that her husband Ben had a shingles rash on his abdomen that resolved 2 weeks ago, but he has been complaining that wearing a shirt hurts his skin. He did not receive a herpes zoster vaccine. What is Ben experiencing?

5. Which of these complications is the most likely consequence of skipping influenza vaccination?

6. Which best describes a potential barrier to herpes zoster vaccination?

7. When considering CDC's “SHARE” model, which of the following is an appropriate way to address patients' barriers to vaccine administration?

8. Which of the following vaccines is NOT paid for by Medicare Part B?

9. Anne is a 70-year-old patient who comes to your pharmacy for an influenza vaccine. She received her first dose of RZV at your location 3 months ago and PCV13 16 months ago. Which is the most appropriate recommendation for Anne?

« Return to Activity

Customers who Purchased
this Activity also Purchased